Recombinant alpha-antitrypsin - AlteogenAlternative Names: Recombinant A1AT - Alteogen
Latest Information Update: 23 Dec 2015
At a glance
- Originator Alteogen
- Class Acute-phase proteins; Alpha globulins; Blood proteins; Secretory proteinase inhibitory proteins; Serpins
- Mechanism of Action Serine endopeptidase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Emphysema
Most Recent Events
- 23 Dec 2015 Preclinical trials in Emphysema in South Korea (unspecified route)